Mylan and UpJohn - New Champion for Global Health
championforglobalhealth.com
Together, uniquely positioned to
fulfill the worlds need for medicine.
Mylan and UpJohn - New Champion for Global Health
championforglobalhealth.com
A global health company well
positioned to fulfill the worlds need for medicine
Mylan and UpJohn - New Champion for Global Health
championforglobalhealth.com
A new global healthcare company with
enhanced scale and geographic reach.
Forward-Looking Statements
This communication contains forward-looking statements. These statements are made pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Such forward-looking statements may include, without limitation, statements about the proposed transaction, the expected timetable for completing the proposed transaction, the benefits and synergies of the proposed
transaction, future opportunities for the combined company and products and any other statements regarding Pfizers, Mylans and Newcos future operations, financial or operating results, capital allocation, dividend policy, debt
ratio, anticipated business levels, future earnings, planned activities, anticipated growth, market opportunities, strategies, competitions, and other expectations and targets for future periods. Forward-looking statements may often be identified by
the use of words such as will, may, could, should, would, project, believe, anticipate, expect, plan, estimate,
forecast, potential, intend, continue, target and variations of these words or comparable words. Because forward-looking statements inherently involve risks and uncertainties, actual future
results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: the parties ability to meet expectations regarding
the timing, completion and accounting and tax treatments of the proposed transaction; changes in relevant tax and other laws; the parties ability to consummate the proposed transaction; the conditions to the completion of the proposed
transaction, including receipt of approval of Mylans shareholders, not being satisfied or waived on the anticipated timeframe or at all; the regulatory approvals required for the proposed transaction not being obtained on the terms expected or
on the anticipated schedule or at all; inherent uncertainties involved in the estimates and judgments used in the preparation of financial statements and the providing of estimates of financial measures, in accordance with the accounting principles
generally accepted in the United States of America (U.S. GAAP) and related standards, or on an adjusted basis
(Non-GAAP
measures); the integration of Mylan and Newco being more
difficult, time consuming or costly than expected; Mylans and Upjohns failure to achieve expected or targeted future financial and operating